semaglutide alcohol use disorder GLP-1 Drug Substantially Reduced Heavy Consumption and Weight in Patients with Alcohol and Obesity Novo Nordisk Begins a 240

This is a process where your prescribing clinician submits documentation to Aetna proving that the medication is medically necessary for you

Fewer calories burned = harder to maintain weight loss

thus, they are an attractive therapeutic option for patients with type 2 diabetes, especially those with existing cardiovascular disease or at high risk for those complications

Such individuals are subject to risk stratification to determine the merit of periodic imaging with EUS or MRI/MRCP

Regular check-ins with your healthcare provider can also aid in addressing any concerns and optimizing the benefits of Semaglutide therapy